Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Don Wingerter
AddedMar 31, 2024
UpdatedMay 1, 2026
Don Wingerter

Don Wingerter

CEO, DMI Life Sciences

Don Wingerter's Career

DMI Life Sciences
DMI Life Sciences

Greenwood Village, CO, US

CEO· C-Suite · Management
Sound Surgical Technologies
Sound Surgical Technologies

Louisville, CO, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Don Wingerter's Career

DMI Life Sciences
DMI Life Sciences
$1.2M62009Greenwood Village, CO, US
CEO· C-Suite · Management

Leadership at DMI Life Sciences

Mike MacalusoMike MacalusoBoard Member
David Bar-OrDavid Bar-OrCo-Founder

Similar to DMI Life Sciences

Dianomi TherapeuticsDianomi TherapeuticsMadison, WI, USBiopharmaceuticalsest. 2017Dianomi TherapeuticsMadison, WI, US · est. 2017

Dianomi Therapeutics: Innovating biopharmaceuticals for enhanced treatment of inflammatory diseases.

Seed · $3.2M6
ImidomicsImidomicsSan Francisco, CA, USBiotechnology, Drug Discovery, Therapeuticsest. 2015ImidomicsSan Francisco, CA, US · est. 2015

IMIDomics, Inc.: A biotech firm innovating new treatments for immune-inflammatory diseases.

Public · $16.5M23
ISI Life SciencesISI Life SciencesNewport Beach, CA, USPharmaceuticalsest. 2011ISI Life SciencesNewport Beach, CA, US · est. 2011

ISI Life Sciences, Inc.: A Newport Beach-based biotech firm specializing in pharmaceuticals since 2011.

Angel · $354.1k3
DiamirDiamirMonmouth Junction, NJ, USBiomarkers, Diagnosticsest. 2009DiamirMonmouth Junction, NJ, US · est. 2009

DiamiR: A leading molecular diagnostics firm, innovating early detection solutions for brain health conditions.

Series A · $7.5M30
Sound Surgical Technologies
Sound Surgical Technologies
$2.1M01998Louisville, CO, US
Board Member· Board

Leadership at Sound Surgical Technologies

Kelly McCrannKelly McCrannBoard Member
William CiminoWilliam CiminoBoard Member
Lawrence J Ciancia \"Larry\"Lawrence J Ciancia \"Larry\"Board Member

Similar to Sound Surgical Technologies

SientraSientraSanta Barbara, CA, USMedical Devicesest. 2003SientraSanta Barbara, CA, US · est. 2003

Sientra, Inc.: US-based manufacturer and marketer of plastic surgery and aesthetic medicine devices.

Public · $334.7M304
SonicSurg InnovationsSonicSurg InnovationsLakeland, FL, USMedical Devicesest. 2009SonicSurg InnovationsLakeland, FL, US · est. 2009

SonicSurg Innovations: Florida-based medical device developer for treating trigger finger and broken bones.

Seed · $1.5M6
Biosculpture TechnologyBiosculpture TechnologyWest Palm Beach, FL, USMedical Devicesest. 2001Biosculpture TechnologyWest Palm Beach, FL, US · est. 2001

BioSculpture Technology: Innovating adipose tissue handling devices for liposuction, body sculpting, and stem cell markets.

Seed · $475.3k30
EndoSoundEndoSoundPortland, OR, USMedical Devicesest. 2016EndoSoundPortland, OR, US · est. 2016

EndoSound: Pioneering technology for advanced endoscopic ultrasound solutions.

Angel · $410.8k12

People Similar to Don Wingerter

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoGilbert DávilaGilbert DávilaBoard Member · Banner HealthDon CoxDon CoxCEO · BioMedical Technologies SolutionsJerry McLaughlinJerry McLaughlinBoard Member · Life BiosciencesMark WestermanMark WestermanCEO · Intrinsic LifeSciencesDale PfostDale PfostCEO · Receptor BioLogixScott H CramerScott H CramerBoard Member · AccuVein